InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Taysha Gene Therapies, Inc.

TSHA Clue Score55
United States Fiscal year ends December CIK 0001806310 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Kamran Alam
4 Feb 2026
Chief Financial Officer
Sell
1,655
$4.52
$7.48K
Kamran Alam
26 Jan 2026
Chief Financial Officer
Sell
23,849
$4.61
$109.94K
Sean P. Nolan
26 Jan 2026
Chief Executive Officer
Sell
41,312
$4.61
$190.45K
Sukumar Nagendran
26 Jan 2026
President and Head of R&D
Sell
26,918
$4.61
$124.09K
Kamran Alam
23 Jan 2026
Chief Financial Officer
Sell
78,968
$4.75
$375.10K
Sean P. Nolan
23 Jan 2026
Chief Executive Officer
Sell
136,789
$4.75
$649.75K
Sukumar Nagendran
23 Jan 2026
President and Head of R&D
Sell
89,132
$4.75
$423.38K
Show all 12 transactions →

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 4
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 2,468,533
History held since 25 Sep 2020